Research Topics
Species | M KivipeltoSummaryAffiliation: Karolinska Institutet Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Statin therapy in Alzheimer's diseaseMiia Kivipelto
Lancet Neurol 4:521-2. 2005
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer diseaseMiia Kivipelto
Aging Research Center, Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Arch Neurol 62:1556-60. 2005..Vascular risk factors play a role in the development of dementia, including Alzheimer disease (AD). However, little is known about the effect of body mass index and clustering of vascular risk factors on the development of dementia...
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based studyMiia Kivipelto
Aging Research Center, Karolinska Institutet, Stockholm, Sweden
Lancet Neurol 5:735-41. 2006..Several vascular risk factors are associated with dementia. We sought to develop a simple method for the prediction of the risk of late-life dementia in people of middle age on the basis of their risk profiles...
Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based studyMiia Kivipelto
Aging Research Center, NVS, Karolinska Institutet, Stockholm, Sweden
J Cell Mol Med 12:2762-71. 2008..The apoE epsilon4 carriers may be more vulnerable to environmental factors, and thus, lifestyle interventions may greatly modify dementia risk particularly among the genetically susceptible individuals...
Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidenceM Kivipelto
Department of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
Acta Neurol Scand Suppl 185:50-7. 2006....
Alzheimer's disease - the ways of preventionM Kivipelto
Aging Research Center, Karolinska Institutet, Gavlegatan 16, S 113 30 Stockholm, Sweden
J Nutr Health Aging 12:89S-94S. 2008..The interplay of genes and environment in the aetiology of AD needs to be further investigated as well as the role of lifestyle and pharmacological interventions for the prevention of dementia...
Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective studyM Kivipelto
Aging Research Center, Karolinska Institutet and Stockholm Gerontology Research Center, Stockholm, Sweden
Eur J Neurol 16:808-13. 2009..Another marker of vitamin B12 deficiency, holo-transcobalamin (holo-TC), has not been studied in a prospective setting...
Education and dementia: what lies behind the association?T Ngandu
Aging Research Center, Karolinska Institutet, Gavlegatan 16, 11330 Stockholm, Sweden
Neurology 69:1442-50. 2007..People with low education have unhealthier lifestyles and more cardiovascular risk factors, but it is unclear how this affects the association between education and dementia...
Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal studyB Hooshmand
Aging Research Center, KarolinskaInstitutet, Stockholm, Sweden
J Intern Med 271:204-12. 2012....
Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based studyM H Laitinen
Aging Research Center, Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Dement Geriatr Cogn Disord 22:99-107. 2006..Thus, dietary interventions may potentially modify the risk of dementia, particularly among genetically susceptible individuals...
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal studyB Hooshmand
Aging Research Center, Department of Neurobiology, Care Sciences and Society NVS, Karolinska Institutet, Gavlegatan 16, S 113 30, Stockholm, Sweden
Neurology 75:1408-14. 2010..To examine the relation between serum levels of homocysteine (tHcy) and holotranscobalamin (holoTC), the active fraction of vitamin B12, and risk of incident Alzheimer disease (AD) in a sample of Finnish community-dwelling elderly...
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's diseaseSuvi Rovio
Aging Research Center, Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Stockholm, Sweden
Lancet Neurol 4:705-11. 2005..Regular physical activity may reduce the risk or delay the onset of dementia and AD, especially among genetically susceptible individuals...
Clinical trials in mild cognitive impairment: lessons for the futureV Jelic
Karolinska Institutet, Neurotec Department, Division of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden
J Neurol Neurosurg Psychiatry 77:429-38. 2006....
Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sexC Qiu
Ageing Research Centre, Division of Geriatric Epidemiology and Medicine, Department of Neurotec, Karolinska Institutet and the Stockholm Gerontology Research Centre, Stockholm, Sweden
J Neurol Neurosurg Psychiatry 75:828-33. 2004..The risk effect of APOE epsilon 4 allele for Alzheimer's disease is acknowledged, whereas the putative protective effect of epsilon 2 allele remains in debate...
The new cholesterol controversy - a little bit of history repeating?M Kivipelto
Department of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
Acta Neurol Scand Suppl 185:1-2. 2006
Alzheimer's Disease: back to the futureM Kivipelto
Department of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
Acta Neurol Scand Suppl 185:119-20. 2006
Work-related physical activity and the risk of dementia and Alzheimer's diseaseSuvi Rovio
Aging Research Center, NVS, Karolinska Institutet, Stockholm, Sweden
Int J Geriatr Psychiatry 22:874-82. 2007..This study aimed to clarify the association between work-related physical activity and dementia/AD...
A prospective study on the development of Alzheimer's disease with regard to thyroid-stimulating hormone and homocysteineSylvia Annerbo
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
Dement Geriatr Cogn Disord 28:275-80. 2009..Our objective was to prospectively investigate the association between tHcy and TSH and the subsequent development of AD...
High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced ageFrancesca Mangialasche
Aging Research Center, Karolinska Institutet, Stockholm, Sweden
J Alzheimers Dis 20:1029-37. 2010..The neuroprotective effect of vitamin E seems to be related to the combination of different forms, rather than to alpha-tocopherol alone, whose efficacy in interventions against AD is currently debated...
Alcohol drinking and cognitive functions: findings from the Cardiovascular Risk Factors Aging and Dementia (CAIDE) StudyTiia Ngandu
Aging Research Center ARC, Karolinska Institutet, Stockholm, Sweden
Dement Geriatr Cogn Disord 23:140-9. 2007..Little is known about the effects of midlife alcohol drinking on the cognitive functions later in life...
Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disordersMarjan Shafaati
Department of Laboratory Medicine, Division of Clinical Chemistry, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Neurosci Lett 425:78-82. 2007..The levels of apoE in cerebrospinal fluid were also correlated to the levels of Tau and the possibility is discussed that the level of apoE in cerebrospinal fluid may be used as a marker of neurodegeneration...
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward interventionChengxuan Qiu
Aging Research Center, Karolinska Institutet Stockholm, Sweden
Dialogues Clin Neurosci 11:111-28. 2009....
The effect of midlife physical activity on structural brain changes in the elderlySuvi Rovio
Aging Research Center, Karolinska Institutet, Gavlegatan 16, 11330 Stockholm, Sweden
Neurobiol Aging 31:1927-36. 2010..The differences in the GM density localized mainly in frontal lobes. There was no significant association between midlife physical activity and severe WML later in life after full adjustments (OR 4.20, 95% CI 0.26-69.13, p=0.32)...
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentB Winblad
Division of Geriatric Medicine, Neurotec Department, Karolinska Institutet, 11382 Stockholm, Sweden
J Intern Med 256:240-6. 2004....
Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia?. A study from the kungsholmen projectHedda Aguero-Torres
Aging Research Center ARC, Karolinska Institutet, Stockholm, Sweden
Dement Geriatr Cogn Disord 22:244-9. 2006..To explore the hypothesis that older adults often are affected by more than one disease, making the differential diagnosis between Alzheimer's disease (AD) and vascular dementia (VaD) difficult...
Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based studyTiia Anttila
Aging Research Center, Division of Geriatric Epidemiology, Neurotec, Karolinska Institutet, Box 6401, 11382 Stockholm, Sweden
BMJ 329:539. 2004..Risk of dementia increased with increasing alcohol consumption only in those individuals carrying the apolipoprotein e4 allele...
Cholesterol-modifying strategies for Alzheimer's diseaseAlina Solomon
Aging Research Center, Karolinska Institutet, Sweden
Expert Rev Neurother 9:695-709. 2009....
Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?Valerio Leoni
Department of Laboratory Medicine, Division of Clinical Chemistry, Karolinska Institutet, Karolinska University Hospital in Huddinge, Stockholm, Sweden
Neurosci Lett 397:83-7. 2006..In patients with AD, the percentages of those with increased levels of 24OHC, tau and phospho tau were similar (55-67%). In this pilot study, we discuss the possibility that 24OHC may be a sensitive test for MCI...
Alzheimer's disease: clinical trials and drug developmentFrancesca Mangialasche
Aging Research Center, Karolinska Institutet, Stockholm, Sweden
Lancet Neurol 9:702-16. 2010....
Memantine offers new possibilities for the treatment of VaDBengt Winblad
Karolinska Institutet, Neurotec, Division of Geriatric Medicine and Geriatric Epidemiology, Huddinge University Hospital, 141 86 Stockholm, Sweden
Lancet Neurol 1:469. 2002
High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient miceAtiqur Rahman
Karolinska Institutet, Neurotec Department, Division of Experimental Geriatrics, Novum, Karolinska University Hospital, SE 14186 Huddinge, Sweden
FEBS Lett 579:6411-6. 2005..Our results suggest an interaction between dietary and genetic factors in the development of tauopathies, which can be relevant in humans, where the apoE4 isoform could have a lack of function as compared to other isoforms...
The International Network on Public Health and Aging (INOPA): introducing a life course perspective to the public health agendaAke Wahlin
Department of Psychology, Stockholm University, 106 91, Stockholm, Sweden
J Cross Cult Gerontol 23:97-105. 2008....
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factorsRaj N Kalaria
Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
Lancet Neurol 7:812-26. 2008..Dementia costs in developing countries are estimated to be US$73 billion yearly, but care demands social protection, which seems scarce in these regions...
Hippocampus and entorhinal cortex in mild cognitive impairment and early ADCorina Pennanen
Department of Neuroscience and Neurology, University of Kuopio and Brain Research Unit, Clinical Research Center, Mediteknia, P.O. Box 1627, FIN-70 211 Kuopio, Finland
Neurobiol Aging 25:303-10. 2004..Our results suggest that the ERC atrophy precedes hippocampal atrophy in AD. The ERC volume loss is dominant over the hippocampal volume loss in MCI, whereas more pronounced hippocampal volume loss appears in mild AD...
[Genetics of Alzheimer's disease]Mikko Hiltunen
Kuopion yliopisto, Neurologian klinikka, Mediteknia
Duodecim 120:2425-31. 2004
Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and olderDavid Bunce
Department of Psychology, Goldsmiths College, University of London, London, United Kingdom
Neuropsychology 18:362-70. 2004..A similar, but nonsignificant, trend was evident in relation to folate. The research is discussed with reference to vulnerability models and genetic influences on brain reserves...
The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric studyCorina Pennanen
Department of Neuroscience and Neurology, University of Kuopio, Canthia, Kuopio, Finland
Dement Geriatr Cogn Disord 22:60-6. 2006..In cases homozygous for the epsilon4 allele (n = 8) versus noncarriers, the greatest atrophy was located in the right amygdala followed by the right parahippocampal gyrus, the left amygdala and the left medial dorsal thalamic nucleus...
Metabolic syndrome and cognitive function: a population-based follow-up study in elderly womenPirjo Komulainen
Kuopio Research Institute of Exercise Medicine, Department of Physiology, University of Kuopio, Kuopio, Finland
Dement Geriatr Cogn Disord 23:29-34. 2007..To test the hypothesis that metabolic syndrome predicts cognitive impairment, and to examine the association of single metabolic risk factors with cognitive functioning...
Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjectsSusanna Tervo
Department of Neuroscience and Neurology, Brain Research Unit, Clinical Research Centre, Mediteknia, University of Kuopio, Kuopio, Finland
Dement Geriatr Cogn Disord 17:196-203. 2004..Both the apolipoprotein E (ApoE) epsilon4 allele and vascular factors have been associated with a higher risk for AD, recently they have also been linked to the risk of MCI...
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer diseaseMiia Kivipelto
University of Kuopio, Department of Neuroscience and Neurology, PO Box 1627, 70211 Kuopio, Finland
Ann Intern Med 137:149-55. 2002..Elevated midlife values for total cholesterol level and blood pressure have been implicated recently as risk factors for Alzheimer disease...
Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological interventionMiia Kivipelto
Department of Neuroscience and Neurology, University of Kuopio, Kuopio, Finland
CNS Drugs 16:435-44. 2002..Based on these data, we propose that proper, early interventions aimed at reducing these cardiovascular risk factors may have an impact on the future incidence and prevalence of Alzheimer's disease...
Acetylcholinesterase and its inhibition in Alzheimer diseaseRoger M Lane
Novartis Neuroscience, Novartis Pharmaceuticals Corp, East Hanover, NJ 07936 1080, USA
Clin Neuropharmacol 27:141-9. 2004..If such differences between ChE-Is are shown to have clinical correlates, this may prompt reconsideration of the rationale and expectations of some agents in the long-term management of AD...
Serum lipids and hippocampal volume: the link to Alzheimer's disease?Henrike Wolf
Department of Psychiatry, University of Leipzig, Leipzig, Germany
Ann Neurol 56:745-8. 2004..This is compatible with protective effects of high-density lipoprotein cholesterol on hippocampal atrophy and Alzheimer's disease...
Hypertension and white matter lesions of the brainMiia Kivipelto
J Hypertens 20:387-9. 2002
Apolipoprotein E, B vitamins, and cognitive function in older adultsDavid Bunce
Department of Psychology, Goldsmiths College, University of London, London, SE14 6NW, UK
J Gerontol B Psychol Sci Soc Sci 60:P41-8. 2005..This finding was unrelated to incipient dementia up to 6 years following testing. The results are discussed with reference to the neuroanatomical reserves that epsilon4 carriers may possess...
A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's diseaseTaru Tukiainen
Computational Medicine Research Group, Department of Biomedical Engineering and Computational Science, Helsinki University of Technology, P O Box 9203, FI 02015 HUT, Finland
Biochem Biophys Res Commun 375:356-61. 2008..The analyses also feature the role of elevated glycoproteins in the risk for AD, supporting the view that coexistence of inflammation and the MetS forms a high risk condition for cognitive decline...
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristicsRoy W Jones
RICE The Research Institute for the Care of Older People, Royal United Hospital, Bath, United Kingdom
Alzheimers Dement 4:145-53. 2008....
Cerebral embolism and Alzheimer's diseaseMiia Kivipelto
BMJ 332:1104-5. 2006
MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up studyTero Tapiola
Department of Neuroscience and Neurology, University of Kuopio, Brain Research Unit, Clinical Research Center, Mediteknia, 70211 Kuopio, Finland
Neurobiol Aging 29:31-8. 2008..The MTL volumetry helps in identifying among the MCI subjects a group, which is at high risk for developing AD...
Carotid intima-media thickness and cognitive function in elderly women: a population-based studyPirjo Komulainen
Kuopio Research Institute of Exercise Medicine, Kuopio, Finland
Neuroepidemiology 28:207-13. 2007..We investigated whether carotid intima-media thickness (IMT) predicts the risk of cognitive impairment and whether the putative impairment is specific for some cognitive domains...
Serum high sensitivity C-reactive protein and cognitive function in elderly womenPirjo Komulainen
Kuopio Research Institute of Exercise Medicine, Finland
Age Ageing 36:443-8. 2007..Inflammation has been linked to cognitive impairment. However, limited data are available on the association between inflammatory markers and cognitive function...
Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairmentAnne Hämäläinen
Department of Neurology, University of Kuopio and Brain Research Unit, Clinical Research Center, Mediteknia, and Kuopio University Hospital, Finland
Neuroimage 37:1122-31. 2007..We conclude that widespread cortical atrophy is present already two and a half years before a clinical diagnosis of dementia can be set...
